חדשות ואירועים RevitalVision

Register for news & events
News icon

May2022

RevitalVision at the AAO 2022 mid year press relase

We are proud to be one of the 10 companies chosen by the AOA committee to be eye care game changers and will impact how optometrists will practice in years to come!!
AAO 2022 mid year press relase
News icon

March 2022

New randomized controlled trial on RevitalVision

Effects of Perceptual Learning on Deprivation Amblyopia in Children with Limbal Dermoid: A Randomized Controlled Trial

The study compared 2 groups of children with amblyopia after corneal transplant : One group received standard patching therapy and the second group received patching + RevitalVision.

The group that underwent RevitalVision therapy experienced statistically significant improvement in vision.

Read the full study
News icon

March 2022

RevitalVision will present at the AAPOS 2022 – Arizona

2022 Annual Meeting of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS), on March 23-27, 2022.

News icon

RevitalVision at HIMSS 22

This year, the Israel Export Institute together with the Foreign Trade Administration – Ministry of Economy & Industry will present 18Israeli Digital Health companies. And we are proud to be amongst these innovative companies

News icon

November 2021

RevitalVision on The Ophthalmologist

Yair Yahav, CEO and founder of RevitalVision, was interviewed in The Ophthalmologist about how we improve vision in adult amblyopia

News icon

July 2021

RevitalVision received reimbursement code in the USA

RevitalVision is a standalone therapeutic vision training software, the only FDA-approved product for market, and clinically proven to improve vision in adult amblyopia (age 9-plus), received a unique Current Procedural Terminology (CPT) reimbursement code from the American Medical Association (AMA).

1 2 3 4 5

יצירת קשר

    טלשיר טכנולוגיות רפואיות בע"מ
    רח' המעיין 2, מודיעין, ישראל, 7177871
    טלפון: 077-2123272 | info@revitalvision.com